Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$1.56 - $2.38 $28,427 - $43,370
-18,223 Reduced 33.8%
35,692 $68,000
Q1 2023

May 15, 2023

SELL
$1.25 - $1.86 $28,743 - $42,770
-22,995 Reduced 29.9%
53,915 $96,000
Q4 2022

Feb 14, 2023

SELL
$1.18 - $2.32 $28,041 - $55,132
-23,764 Reduced 23.6%
76,910 $95,000
Q3 2022

Nov 14, 2022

SELL
$1.65 - $3.42 $82,991 - $172,019
-50,298 Reduced 33.32%
100,674 $192,000
Q2 2022

Aug 15, 2022

SELL
$1.85 - $3.22 $48,549 - $84,502
-26,243 Reduced 14.81%
150,972 $460,000
Q1 2022

May 16, 2022

BUY
$3.01 - $4.81 $14,866 - $23,756
4,939 Added 2.87%
177,215 $533,000
Q4 2021

Feb 14, 2022

SELL
$3.36 - $5.34 $434,155 - $689,997
-129,213 Reduced 42.86%
172,276 $779,000
Q3 2021

Nov 15, 2021

BUY
$3.3 - $6.49 $109,038 - $214,442
33,042 Added 12.31%
301,489 $1.68 Million
Q2 2021

Aug 16, 2021

BUY
$3.35 - $5.67 $899,297 - $1.52 Million
268,447 New
268,447 $964,000
Q1 2021

May 17, 2021

SELL
$4.75 - $6.87 $84,830 - $122,691
-17,859 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$5.35 - $7.77 $95,545 - $138,764
17,859 New
17,859 $96,000
Q2 2020

Aug 14, 2020

SELL
$4.93 - $10.26 $855,078 - $1.78 Million
-173,444 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$2.58 - $6.6 $413,344 - $1.06 Million
160,211 Added 1210.69%
173,444 $902,000
Q4 2019

Feb 14, 2020

BUY
$5.02 - $6.66 $66,429 - $88,131
13,233 New
13,233 $69,000
Q3 2019

Nov 14, 2019

SELL
$4.98 - $6.7 $140,724 - $189,328
-28,258 Closed
0 $0
Q2 2019

Aug 15, 2019

SELL
$3.15 - $6.95 $768,839 - $1.7 Million
-244,076 Reduced 89.62%
28,258 $177,000
Q2 2019

Aug 14, 2019

BUY
$3.15 - $6.95 $857,852 - $1.89 Million
272,334 New
272,334 $257,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $51.7M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.